Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience

Detalles Bibliográficos
Autores principales: Sannareddy, Aishwarya, Reves, Heather, Jaleta, Kefyalew, .Ramiahsankarasubramanian, Ramyakumari, Patel, Hetalkumari, Narasimhan, Madhusudhanan, Anderson, Larry D., Afrough, Aimaz, Chung, Stephen S., Collins, Robert H., Kaur, Gurbakhash, Kumar, Kiran A, Madanat, Yazan F., Vusirikala, Madhuri, Awan, Farrukh T., Muthukumar, Alagarraju, Ramakrishnan Geethakumari, Praveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665303/
http://dx.doi.org/10.1182/blood-2022-171001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665303/
http://dx.doi.org/10.1182/blood-2022-171001

Ejemplares similares